ESPR

ESPERION THERAPEUTICS INC NE

ESPR·29664W105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

ESPR (ESPERION THERAPEUTICS INC NE) is held by 99 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($69.9M), VANGUARD CAPITAL MANAGEMENT LLC ($36.1M), GOLDMAN SACHS GROUP INC ($32.8M). Net institutional sentiment: Mixed.

99
Holders
(6 Elite)
$364M
Total Value
48% (118)
Consensus
57 buying - 61 selling
13F: Insider & Congress: Updated regularly
ESPR

Smart Money Verdict

View all
Loading verdict
Held by 99 funds
6 elite

Who's Trading

Source dates: Price Jul 13, 2026 · Insiders Jul 13, 2026 · Activists Aug 13, 2026 · Congress none

ActivistTHE GOLDMAN SACHS GROUP, INC.THE GOLDMAN SACHS GROUP, INC.6.7%Aug 13, 2026
ActivistVAVanguard Capital Management5.1%Jul 31, 2026
ActivistWasatch Advisors LPWasatch Advisors LP0.7%Jul 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
22.1M(+23.9%)$69.9M0.0%+25.55%
36
Increased
11.4M(+9.5%)$36.1M0.0%+8.47%
32
Increased
10.4M(+330.6%)$32.8M0.0%+2.42%
47
Increased
7.3M(+3.1%)$23M0.0%+17.02%
29
Decreased
7.1M(-24.6%)$22.5M0.0%-1.59%
0
Increased
6.6M(+11.3%)$21M0.0%-25.76%
32
New
4.7M$14.7M0.0%+0.63%
39
Increased
4.6M(+1131.8%)$14.6M0.0%+1.52%
45
Decreased
3.8M(-10.6%)$12.1M0.0%+13.20%
0
Increased
3.6M(+1270.6%)$9.8M0.0%+3.23%
45
New
2.9M$9.1M0.1%+0.63%
38
Decreased
2.5M(-30.0%)$7.8M0.0%+9.28%
0
Increased
2.3M(+10.3%)$7.3M0.0%-4.23%
30
Increased
2.2M(+268.3%)$7M0.0%-1.91%
44
New
2.1M$6.7M0.0%+0.63%
38
Decreased
1.9M(-87.8%)$6.1M0.0%-17.18%
0
Increased
1.7M(+11.1%)$5.5M0.0%+8.35%
30
Increased
1.6M(+4381.9%)$5.1M0.0%+0.81%
43
Increased
1.4M(+103.7%)$4.4M0.0%+12.24%
43
New
1.3M$4M0.0%+0.63%
37

Showing 1-20 of 124

1 / 7
ESPRESPRESPERION THERAPEUTICS INC NE

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used